Defining the role of the tumor microenvironment in treatment resistance of OVArian cancer through patient-Derived EXplants (OVADEX)

Informations projet

OVADEX

N° de convention de subvention: 101064216

DOI

10.3030/101064216

Projet clôturé

Date de signature de la CE 9 Juin 2022

Date de début 1 Septembre 2022

Date de fin 31 Août 2024

Financé au titre de

• Marie Skłodowska-Curie Actions (MSCA)

Coût total

Aucune donnée

Contribution de l’UE

€ 175 920,00

Coordonné par

KATHOLIEKE UNIVERSITEIT LEUVEN
Belgium

CORDIS fournit des liens vers les livrables publics et les publications des projets HORIZON.

Les liens vers les livrables et les publications des projets du 7e PC, ainsi que les liens vers certains types de résultats spécifiques tels que les jeux de données et les logiciels, sont récupérés dynamiquement sur OpenAIRE .

Livrables

Documents, reports (1)

Communication, Dissemination & Outreach Plan

The plan describes the planned measures to maximize the impact ofthe project, including the dissemination and exploitation measures that are planned,and the target group(s) addressed. Regarding communication measures and publicengagement strategy, the aim is to inform and reach out to society and show theactivities performed, and the use and the benefits the project will have for citizens

Data Management Plan (1)

Data Management Plan

The Data Management Plan describes the data management life cyclefor all data sets that will be collected processed or generated by the action It is adocument describing what data will be collected processed or generated andfollowing what methodology and standards whether and how this data will beshared andor made open and how it will be curated and preserved

Publications

Peer reviewed articles (3)

An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study)

Auteurs: Trozzi, Rita; Tuyaerts, Sandra; Annibali, Daniela; Pomares, Alejandro Herreros; Boog, Lotte; Van Dam, Peter; Leunen, Karin; Deroose, Christophe; Trum, Hans; Amant, Frederic
Publié dans: International Journal Of Gynecological Cancer, Numéro 34 (8), 1217-1224, 2024, ISSN 1525-1438
Éditeur: BMJ PUBLISHING GROUP
DOI: 10.1136/IJGC-2023-005229

PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6^high uterine leiomyosarcoma to PD‐1 blockade

Auteurs: Wout De Wispelaere; Daniela Annibali; Sandra Tuyaerts; Julie Messiaen; Asier Antoranz; Gautam Shankar; Nikolina Dubroja; Alejandro Herreros‐Pomares; Regina E. M. Baiden‐Amissah; Marie‐Pauline Orban; Marcello Delfini; Emanuele Berardi; Thomas Van Brussel; Rogier Schepers; Gino Philips; Bram Boeckx; Maria Francesca Baietti; Luigi Congedo; Kiave Yune HoWangYin; Emilie Bayon; Anne‐Sophie Van Rompuy; Eleonora Leucci; Sebastien P. Tabruyn; Francesca Bosisio; Massimiliano Mazzone; Diether Lambrechts; Frédéric Amant
Publié dans: Clinical and Translational Medicine, Vol 14, Iss 5, Pp n/a-n/a (2024), Numéro 14(5) e1655, 2024, ISSN 2001-1326
Éditeur: JONH WILEY & SONS LTD
DOI: 10.1002/CTM2.1655

Neutrophil Extracellular Traps and Cancer: Trapping Our Attention with Their Involvement in Ovarian Cancer

Auteurs: María Castaño; Sarai Tomás-Pérez; Eva González-Cantó; Cristina Aghababyan; Andrea Mascarós-Martínez; Nuria Santonja; Alejandro Herreros-Pomares; Julia Oto; Pilar Medina; Martin Götte; Bárbara Andrea Mc Cormack; Josep Marí-Alexandre; Juan Gilabert-Estellés
Publié dans: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Numéro 24(6), 5995, 2023, ISSN 1661-6596
Éditeur: MDPI
DOI: 10.3390/IJMS24065995